Loading candles…
Paushak Ltd., headquartered in Gujarat, India, operates as a specialty chemicals manufacturer focusing on phosgene and its derivatives. The company serves the pharmaceutical, agrochemical, and performance chemical industries primarily within India. Paushak is part of the Alembic group of companies, whose parent, Alembic Ltd, was founded in 1907 and is recognized as the oldest pharmaceutical company in India. Paushak runs integrated manufacturing facilities and acts as a strategic supplier to global innovators in the niche and highly regulated phosgene chemistry segment.
This page is a live market overview for PAUSHAK LIMITED (PAUSHAKLTD) on the NSE. As a listed security, PAUSHAK LIMITED is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for PAUSHAKLTD before placing trades on tick2trade.
As of the latest feed, PAUSHAKLTD last traded at ₹710 on NSE, up ₹9.05 (1.29%) from the previous close of ₹700.95. Today's session range is ₹700.95 – ₹710, against a 52-week band of ₹342.5 – ₹826.75. Traded volume today stands at 2.41K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for PAUSHAKLTD in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether PAUSHAKLTD is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for PAUSHAK LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in PAUSHAKLTD. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated PAUSHAKLTD option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Results - FY26 | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters | 30 Jul 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026, dividend and other business matters | 5 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 and other business matters | 27 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.